Loading…

CEM Corporation has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, based in Cologne, Germany, to strengthen its peptide synthesis and life sciences product offering.
“We are very pleased to be acquiring the Intavis line of instruments and unique robotic technology.”news-medical.net
Summarized from public sources; check the original articles before acting on it.